GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Goodwill-to-Asset

Kimia Biosciences (BOM:530313) Goodwill-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Kimia Biosciences's Goodwill for the quarter that ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Total Assets for the quarter that ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Goodwill-to-Asset Historical Data

The historical data trend for Kimia Biosciences's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Goodwill-to-Asset Chart

Kimia Biosciences Annual Data
Trend
Goodwill-to-Asset

Kimia Biosciences Semi-Annual Data
Goodwill-to-Asset

Competitive Comparison of Kimia Biosciences's Goodwill-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's Goodwill-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Goodwill-to-Asset falls into.



Kimia Biosciences Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Kimia Biosciences's Goodwill to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Goodwill to Asset (A: . 20 )=Goodwill/Total Assets
=/
=

Kimia Biosciences's Goodwill to Asset Ratio for the quarter that ended in . 20 is calculated as

Goodwill to Asset (Q: . 20 )=Goodwill/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kimia Biosciences  (BOM:530313) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Kimia Biosciences Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines